717857-25-5

Basic information

• Product Name: N-(biphenyl-2-yl)iso-nicotinamide
• CAS NO: 717857-25-5
• Molecular Weight: 274.322
• Mol File: 717857-25-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-(biphenyl-2-yl)iso-nicotinamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(biphenyl-2-yl)iso-nicotinamide(717857-25-5)
• EPA Substance Registry System: N-(biphenyl-2-yl)iso-nicotinamide(717857-25-5)

Safety Data

• Hazardous Substances Data: 717857-25-5(Hazardous Substances Data)

Upstream product

• 39178-35-3 isonicotinoyl chloride hydrochloride 
• 90-41-5 2-phenylaniline 

Relevant articles and documents

Novel compound or pharmaceutically acceptable salt thereof and pharmaceutical composition for prevention or treatment of disease caused by influenza virus infection containing the same as an active ingredient

The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active component for preventing or treating diseases related with influenza virus infection. The novel compound represented by chemical formula 1 has remarkable antivirus activity against influenza virus without cytotoxicity to human cells and thus has little side effects to human bodies. Therefore, the pharmaceutical composition having the same as an active component can be usefully used for preventing or treating diseases which occur through influenza virus infection such as flu, cold, sore throat, bronchitis, pneumonia, avian influenza, swine flu, goat flu, etc.COPYRIGHT KIPO 2016

Novel compound or pharmaceutically acceptable salt thereof and pharmaceutical composition for prevention or treatment of disease caused by influenza virus infection containing the same as an active ingredient

The present invention relates to a novel compound or pharmaceutically acceptable salt thereof, and to a pharmaceutical composition containing the same as an active ingredient for treating and preventing disease caused by influenza virus infection. The novel compound represented by chemical formula 1 according to the present invention not only has extremely excellent antivirus activity, but also has less side effects for a human body by not having cytotoxicity for a human cell. Therefore, a pharmaceutical composition containing the same as an active ingredient can be used in preventing or treating such as flu, colds, sore throats, bronchitis, pneumonia, bird flu, swine flu, and goat flu caused by influenza virus infection.COPYRIGHT KIPO 2015